Dobu is a KONEX-listed maker of industrial and disaster-response respirators. Its standalone revenue for fiscal 2025 (19th term) was KRW 16,451 million, but operating and net losses continued.
A financial structure with KRW 11,127 million in liabilities against KRW 623 million in equity could weigh on financial capacity if losses persist.
On the positive side, certified product lines under the Industrial Safety and Health Act, chemical-protection and emergency evacuation product lines, and export channels to parts of Asia are cited as the business base.
On the negative side, the operating losses since 2024, the thin capital base and overseas channel expansion still at the discussion stage remain open issues.
The share price moved from KRW 789 on March 27, 2026 to KRW 717 on the morning of November 11, 2026, with a one-year return of -56.53% and annual volatility of 34.56%.
The next checkpoints are the operating profit and loss trend in the third-quarter 2026 quarterly report, the business plans presented after the IR event disclosed on September 17, 2026, and whether overseas export results are disclosed.
Taken together, the business base is intact, but whether profitability and the financial structure improve is the central variable.